Efficacy of Nucleotide/Nucleoside Analogues and Hepatitis B Immunoglobulin Therapy in Blocking Mother-to-Child Transmission of Hepatitis B in an Eastern Chinese Group
Table 1
Study groups and treatments.
Groups
Cases
Treatments
Telbivudine group
60
Telbivudine 600 mg qd, from 26 gestational weeks to 4 weeks postpartum
Tenofovir group
60
Tenofovir 300 mg qd, from 26 gestational weeks to 4 weeks postpartum
Lamivudine group
60
Lamivudine 100 mg qd, from 26 gestational weeks to 4 weeks postpartum
HBIG group
30
HBIG 200 IU/4 weeks for 3 times from 26 gestational weeks
